Authors:
SCOTT WK
YAMAOKA LH
STAJICH JM
SPEER MC
SCOTT BL
NANCE M
HUBBLE J
WATTS RL
KOLLER W
JANKOVIC J
ONDO W
STERN MB
COLCHER A
HINER BC
ALLEN FH
GOETZ C
PAPPERT E
MASTAGLIA F
LAING NG
SMALL GW
MASTERMAN D
HAINES JL
DAVIS T
AMINOFF M
DOWLING G
VANCE JM
ROSES AD
PERICAKVANCE MA
Citation: Wk. Scott et al., EXCLUSION OF THE ALPHA-SYNUCLEIN GENE AS A MAJOR GENETIC RISK FACTOR IN IDIOPATHIC PARKINSON-DISEASE (PD), Neurology, 50(4), 1998, pp. 53006-53006
Citation: Mb. Stern et al., NANOCHANNEL FABRICATION FOR CHEMICAL SENSORS, Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena, 15(6), 1997, pp. 2887-2891
Authors:
SCOTT WK
STAJICH JM
YAMAOKA LH
SPEER MC
VANCE JM
ROSES AD
PERICAKVANCE MA
NANCE M
HUBBLE J
KOLLER W
STERN MB
COLCHER A
WATTS RL
GOETZ C
PAPPERT E
ALLEN FH
JANKOVIC J
ONDO W
HINER BC
AMINOFF M
DOWLING G
SMALL GW
Citation: Wk. Scott et al., GENETIC COMPLEXITY AND PARKINSONS-DISEASE, Science, 277(5324), 1997, pp. 387-388
Citation: Mb. Stern, CONTEMPORARY APPROACHES TO THE PHARMACOTHERAPEUTIC MANAGEMENT OF PARKINSONS-DISEASE - AN OVERVIEW, Neurology, 49(1), 1997, pp. 2-9
Authors:
HUTTON JT
KOLLER WC
AHLSKOG JE
PAHWA R
HURTIG HI
STERN MB
HINER BC
LIEBERMAN A
PFEIFFER RF
RODNITZKY RL
WATERS CH
MUENTER MD
ADLER CH
MORRIS JL
Citation: Jt. Hutton et al., MULTICENTER, PLACEBO-CONTROLLED TRIAL OF CABERGOLINE TAKEN ONCE-DAILYIN THE TREATMENT OF PARKINSONS-DISEASE, Neurology, 46(4), 1996, pp. 1062-1065
Authors:
STERN MB
PALMATEER SC
HORN MW
ROTHSCHILD M
MAXWELL BE
CURTIN JE
Citation: Mb. Stern et al., PROFILE CONTROL IN DRY DEVELOPMENT OF HIGH-ASPECT-RATIO RESIST STRUCTURES, Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena, 13(6), 1995, pp. 3017-3021
Citation: Rl. Doty et al., OLFACTORY TESTING AS AN AID IN THE DIAGNOSIS OF PARKINSONS-DISEASE - DEVELOPMENT OF OPTIMAL DISCRIMINATION CRITERIA, Neurodegeneration, 4(1), 1995, pp. 93-97
Citation: Sm. Bromley et al., OLFACTORY TESTING AS AN AID IN THE DIAGNOSIS OF PARKINSONS-DISEASE - DEVELOPMENT OF OPTIMAL DISCRIMINATION CRITERIA, Chemical senses, 20(6), 1995, pp. 34-34
Authors:
MCDERMOTT MP
JANKOVIC J
CARTER J
FAHN S
GAUTHIER S
GOETZ CG
GOLBE LI
KOLLER W
LANG AE
OLANOW CW
SHOULSON I
STERN MB
TANNER CM
WEINER WJ
Citation: Mp. Mcdermott et al., FACTORS PREDICTIVE OF THE NEED FOR LEVODOPA THERAPY IN EARLY, UNTREATED PARKINSONS-DISEASE, Archives of neurology, 52(6), 1995, pp. 565-570
Authors:
GROSSMAN M
CARVELL S
GOLLOMP S
STERN MB
REIVICH M
MORRISON D
ALAVI A
HURTIG HI
Citation: M. Grossman et al., COGNITIVE AND PHYSIOLOGICAL SUBSTRATES OF IMPAIRED SENTENCE PROCESSING IN PARKINSONS-DISEASE, Journal of cognitive neuroscience, 5(4), 1993, pp. 480-498
Citation: Be. Skolnick et al., RELIABILITY OF REGIONAL CEREBRAL BLOOD-FLOW ACTIVATION TO COGNITIVE TASKS IN ELDERLY NORMAL SUBJECTS, Journal of cerebral blood flow and metabolism, 13(3), 1993, pp. 448-453